Metronomic chemotherapy or MC is emerging as a therapeutic choice in the treatment of head and neck cancer. Each year, about 60,000 patients will be diagnosed with squamous cell cancer of the head and neck. In spite of advances in surgery, chemotherapy, and radiation therapy, the survival rate of head and neck cancer hasn’t gotten better.
One research article (1) looked at the use of metronomic therapy in the treatment of head and neck cancers. It noted that, in normal chemotherapy, patients are given chemotherapy in cycles, getting high doses of chemotherapeutic drugs for a period of time before taking a temporary break.
Metronomic chemotherapy is given differently. It seems to be able to help people with head and neck cancer without the side effects of traditional chemotherapy agents.
Source: 1.De Felice F, et al. Head and neck cancer: metronomic chemotherapy. BMC Cancer. 2015;15:677.